Targeting the alpha subunit of IL-3 receptor (CD123) in patients with acute leukemia.

Aldoss, Ibrahim; Clark, Mary; Song, Joo Y; Pullarkat, Vinod

Aldoss, Ibrahim; Clark, Mary; Song, Joo Y; Pullarkat, Vinod.

Afiliación

Aldoss I; Gehr Family Center for Leukemia Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center , Duarte, CA, USA.
Clark M; Department of Clinical and Translational Project Development, City of Hope National Medical Center , Duarte, CA, USA.
Song JY; Department of Pathology, City of Hope National Medical Center , Duarte, CA, USA.
Pullarkat V; Gehr Family Center for Leukemia Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center , Duarte, CA, USA.

Hum Vaccin Immunother ; 16(10): 2341-2348, 2020 10 02.

Article en En | MEDLINE | ID: mdl-32692611

Asunto(s)

Leucemia Mieloide Aguda; Leucemia-Linfoma Linfoblástico de Células Precursoras; Humanos; Subunidad alfa del Receptor de Interleucina-3; Leucemia Mieloide Aguda/terapia; Leucemia-Linfoma Linfoblástico de Células Precursoras/terapia; Receptores de Interleucina-3

Palabras clave

ALL; AML; BPDCN; CD123; Il3; bispecific antibody; flotetuzumab; tagraxofusp

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Leucemia-Linfoma Linfoblástico de Células Precursoras Límite: Humans Idioma: En Revista: Hum Vaccin Immunother Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google